| Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation M Connock, A Juarez-Garcia, S Jowett, E Frew, Z Liu, RJ Taylor, ... NIHR Health Technology Assessment programme: Executive Summaries, 2007 | 706 | 2007 |
| Opioid agonist treatment for pharmaceutical opioid dependent people S Nielsen, B Larance, L Degenhardt, L Gowing, C Kehler, N Lintzeris Cochrane Database of Systematic Reviews, 2016 | 350 | 2016 |
| Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic A Dunlop, B Lokuge, D Masters, M Sequeira, P Saul, G Dunlop, J Ryan, ... Harm reduction journal 17 (1), 26, 2020 | 333 | 2020 |
| Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial DJ Allsop, J Copeland, N Lintzeris, AJ Dunlop, M Montebello, C Sadler, ... JAMA psychiatry 71 (3), 281-291, 2014 | 310 | 2014 |
| Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis S Nielsen, P Sabioni, JM Trigo, MA Ware, BD Betz-Stablein, B Murnion, ... Neuropsychopharmacology 42 (9), 1752-1765, 2017 | 294 | 2017 |
| Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study G Campbell, WD Hall, A Peacock, N Lintzeris, R Bruno, B Larance, ... The Lancet Public Health 3 (7), e341-e350, 2018 | 269 | 2018 |
| Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox … J Strang, N Metrebian, N Lintzeris, L Potts, T Carnwath, S Mayet, ... The Lancet 375 (9729), 1885-1895, 2010 | 257 | 2010 |
| Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition TR Arkell, N Lintzeris, RC Kevin, JG Ramaekers, R Vandrey, C Irwin, ... Psychopharmacology 236 (9), 2713-2724, 2019 | 192 | 2019 |
| Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review KJ Siefried, LS Acheson, N Lintzeris, N Ezard CNS drugs 34 (4), 337-365, 2020 | 187 | 2020 |
| Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study L Degenhardt, N Lintzeris, G Campbell, R Bruno, M Cohen, M Farrell, ... Drug and alcohol dependence 147, 144-150, 2015 | 154 | 2015 |
| Oral THC: CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial P Grimison, A Mersiades, A Kirby, N Lintzeris, R Morton, P Haber, I Olver, ... Annals of Oncology 31 (11), 1553-1560, 2020 | 151 | 2020 |
| Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization S Nielsen, N Lintzeris, R Bruno, G Campbell, B Larance, W Hall, B Hoban, ... Pain medicine 16 (2), 356-366, 2015 | 147 | 2015 |
| The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain G Campbell, S Nielsen, R Bruno, N Lintzeris, M Cohen, W Hall, B Larance, ... Pain 156 (2), 231-242, 2015 | 147 | 2015 |
| Benzodiazepines, methadone and buprenorphine: interactions and clinical management N Lintzeris, S Nielsen The American Journal on Addictions 19 (1), 59-72, 2010 | 144 | 2010 |
| Unplanned pregnancy and contraceptive use in women attending drug treatment services KI Black, C Stephens, PS Haber, N Lintzeris Australian and New Zealand Journal of Obstetrics and Gynaecology 52 (2), 146-150, 2012 | 134 | 2012 |
| LAAM maintenance vs methadone maintenance for heroin dependence NC Clark, N Lintzeris, A Gijsbers, G Whelan, A Dunlop, A Ritter, WW Ling, ... Cochrane Database of Systematic Reviews 2010 (1), 1996 | 130 | 1996 |
| A randomized controlled trial of buprenorphine in the management of short‐term ambulatory heroin withdrawal N Lintzeris, J Bell, G Bammer, DJ Jolley, L Rushworth Addiction 97 (11), 1395-1404, 2002 | 124 | 2002 |
| Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment (POINT) cohort G Campbell, S Nielsen, B Larance, R Bruno, R Mattick, W Hall, N Lintzeris, ... Pain Medicine 16 (9), 1745-1758, 2015 | 121 | 2015 |
| Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) N Lintzeris, L Mills, A Suraev, M Bravo, T Arkell, JC Arnold, MJ Benson, ... Harm reduction journal 17, 1-12, 2020 | 114 | 2020 |
| A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial AE Gibson, CM Doran, JR Bell, A Ryan, N Lintzeris Medical Journal of Australia 179 (1), 38-42, 2003 | 113 | 2003 |
